Credit Agricole’s Accelerate Diagnostics AXDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-18,849
Closed -$4.23M 431
2017
Q3
$4.23M Buy
18,849
+9,110
+94% +$2.24M 0.01% 691
2017
Q2
$2.66M Sell
9,739
-1,820
-16% -$493K 0.01% 851
2017
Q1
$2.8M Buy
11,559
+4,910
+74% +$1.12M 0.01% 904
2016
Q4
$1.38M Buy
+6,649
New +$1.58M ﹤0.01% 1027

Other funds holding AXDX

Credit Agricole's AXDX Position: Q4 2017 in Review

Credit Agricole sold out of Accelerate Diagnostics (AXDX) in Q4 2017, closing a stake of 18,849 shares — an estimated $4.23M sold.

Credit Agricole first reported a position in AXDX in Q4 2016 and held it in 4 quarters. The position peaked at $4.23M in Q3 2017. 118 funds tracked by Wall St. Rank hold AXDX as of Q4 2017.

  • Credit Agricole reported no remaining Accelerate Diagnostics position as of Q4 2017 after selling out during the quarter.
  • Credit Agricole sold 18,849 Accelerate Diagnostics shares in Q4 2017, an estimated $4.23M.
  • Credit Agricole first reported a position in Accelerate Diagnostics in Q4 2016 and held it in 4 quarters.
  • Credit Agricole's Accelerate Diagnostics position peaked at $4.23M in Q3 2017.
  • 118 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q4 2017.

Based on Credit Agricole's 13F filing for Q4 2017, filed 13 Feb 2018.